1 有淋巴结转移的NSCLC患者血清Galectin-3浓度显著高于无淋巴结转移患者血清Galectin-3浓度。2同侧纵隔内及(或)隆突下淋巴结(N2)转移患者与同侧支气管周围及(或)同侧肺门淋巴结以及肺内淋巴结(N1)转移患者比较, 血清Galectin-3浓度显著升高。3晚期肺癌患者(III期+IV期)血清Galectin-3浓度显著高于早期肺癌患者(I期+II期)血清Galectin-3浓度。见表 1。. This evidence concerns the gene LGALS3 and non-small cell lung carcinoma.